Key indicators: single-crystal X-ray study; T = 293 K; mean (C-C) = 0.003 Å; disorder in main residue; R factor = 0.053; wR factor = 0.150; data-to-parameter ratio = 12.1.
In the title compound, C 18 H 19 F 3 N 2 O 7 , the tetrahydropyridine ring adopts a half-chair conformation. The nitro group is disordered over two sites with occupancies of 0.780 (15) and 0.220 (15). An intramolecular N-HÁ Á ÁF hydrogen bond is observed in the molecular structure. The molecules are linked into a two-dimensional network parallel to (100) by O-HÁ Á ÁO, N-HÁ Á ÁO and C-HÁ Á ÁO hydrogen bonds.
Related literature
For related literature, see: Achiwa & Kato (1999) ; Dubur et al. (1989) ; Hermann et al. (2003) ; Ulrich (2004) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). 3-Ethyl 5-methyl 2-hydroxy-6-methyl-4-(4-nitrophenyl)-2-trifluoromethyl-1,2,3,4-tetrahydropyridine-3,5-dicarboxylate C.-X. Yu, P.-L. Qian, J.-J. Ping and C.-S. Yao Comment 1,4-Dihydropyridines are well known compounds as a consequence of their pharmacological profile as the most important calcium channel modulators (Achiwa & Kato, 1999) . 4-Aryl-2,6-dimethyl-1,4-dihydropyridine -3,5-dicarboxylate derivatives are widely used for the treatment of cardiovascular diseases such as hypertension, angina pectoris and infarction (Dubur et al., 1989) . In addition, compounds that contain fluorine have special bioactivity, for example, flumioxazin is a widely used herbicide (Hermann et al., 2003; Ulrich,2004) . This led us to pay much attention to the synthesis and bioactivity of these fluoro-compounds. During the synthesis of trifluoromethylated 1,4-dihydropyridine derivatives, an intermediate, the title compound, was isolated. We report here the crystal structure of the title compound.
In the title molecule ( Fig.1) , the pyridine ring adopts a half-chair conformation, with atoms C10 and C11 deviating from the N2/C7/C8/C9 plane by 0.261 (4) Å and -0.544 (4)Å, respectively. The dihedral angle between the N2/C7/C8/C9 and C1-C6 planes is 72.30 (9)°. The N atom of the nitro group adopts a planar configuration in the major disorder component, while pyramidal configuration in the minor disorder component. An intramolecular N2-H2···F2 hydrogen bond is observed in the molecular structure.
The crystal packing is stabilized by O-H···O, N-H···O and C-H···O intermolecular hydrogen bonds (Table 1) which link the molecules into a two-dimensional network parallel to the (1 0 0) (Fig. 2 ).
The title compound was synthesized by the reaction of 4-nitrobenzaldehyde (1 mmol), methyl 3-amino-but-2-enoate (1 mmol) and ethyl 4,4,4-trifluoro-3-oxobutanoate (1 mmol) catalyzed by triethylbenzylaminium chloride (0.02 g) in water (10 ml) at 363 K. After cooling, the reaction mixture was washed with water and recrystallized from ethanol, to obtain single crystals suitable for X-ray diffraction.
Refinement
All H atoms were placed in calculated positions (C-H = 0.93-0.98 Å, O-H = 0.82 Å and N-H = 0.86 Å) and included in the final cycles of refinement using a riding model, with U iso (H) = 1.2U eq (parent atom). Atom O1 is disordered over two positions with site-occupancy factors of 0.220 (15) and 0.780 (15), respectively. The U ij components of disordered atoms were restrained to an approximate isotropic behaviour. The N1-O1 and N1-O1' bond lengths were restrained to 1.22 (2) Å.
supplementary materials sup-2 Symmetry codes: (i) −x+1/2, −y+1/2, −z+2; (ii) x, −y+1, z+1/2; (iii) −x, y, −z+3/2.
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